Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for cancer and autoimmune disease.
86 employees · est. 2020 · Cambridge, United States
Tr1X
Engineering cures for patients with autoimmune & inflammatory diseases.
46 employees · est. 2018 · San Diego, United States
Tr1X is the older company (2020 vs 2018); Repertoire Immune Medicines is the larger of the two.
Side-by-Side Comparison
| Metric | Repertoire Immune Medicines | Tr1X |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2018 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | San Diego, United States |
| Employees | ||
| Employees | 86 larger | 46 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Unknown |
| Total Funding | ||
| Total Funding | $189.00M | $125.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Discovery of Immune Codes, Development of Targeted Immune Medicines, Therapeutic Solutions for Cancer, Therapeutic Solutions for Autoimmune Diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Cancer, Patients with Autoimmune Diseases, Healthcare Providers, Pharmaceutical Partners | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immune Medicines, Cancer Treatment, Autoimmune Disease Treatment, T Cell Repertoire, Immune Synapse, DECODE Platform, T Cell Receptor-epitope Pairs, Immune-based Medicines, Clinical Stage Biotechnology, Autologous T Cell Therapy, IL-15 Tethering, Infectious Disease Treatment, Immune System Innovation, Phenotype Analysis | Cellular Immunotherapies, Autoimmune Diseases, Inflammatory Diseases, Immune System, Cell Therapy, Proprietary Platform, Immune Modulation, Homeostasis, Tolerance, La Jolla, California |
| Website | ||
| Website | repertoire.com | tr1x.bio |
About Repertoire Immune Medicines
Repertoire Immune Medicines is at the forefront of developing a new wave of immune medicines, leveraging its expertise in the biotechnology sector. Founded in 2020 and headquartered in the United States, the company uniquely harnesses the potential of the human T cell repertoire to combat cancer, ta...
About Tr1X
Tr1X Inc. is a biotechnology company founded in 2018, with headquarters in La Jolla, CA. The company's slogan "Engineering cures for patients with autoimmune & inflammatory diseases" encapsulates its dedication to developing novel cellular immunotherapies for patients in need. Tr1X specializes in le...
We will tell you when either one moves
BounceWatch watches Repertoire Immune Medicines and Tr1X for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Repertoire Immune Medi... and Tr1X — by email.
Frequently Asked Questions
Compare Repertoire Immune Medicines with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Repertoire Immune Medicines on 28 Jan 2026, and Tr1X on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
